Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP360844.RAbXBrSv5De6UjyFh0Wgo963zsVoXwlzDudY8c8qfLvM0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP360844.RAbXBrSv5De6UjyFh0Wgo963zsVoXwlzDudY8c8qfLvM0130_assertion type Assertion NP360844.RAbXBrSv5De6UjyFh0Wgo963zsVoXwlzDudY8c8qfLvM0130_head.
- NP360844.RAbXBrSv5De6UjyFh0Wgo963zsVoXwlzDudY8c8qfLvM0130_assertion description "[The incidence of FLT3/ITD was 11.3% (9 out of 80 patients) in AML, with 25% (3 out of 12 patients) in acute promyelocytic leukemia (APL) and 8.8% (6 out of 68 patients) in non-M3 AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP360844.RAbXBrSv5De6UjyFh0Wgo963zsVoXwlzDudY8c8qfLvM0130_provenance.
- NP360844.RAbXBrSv5De6UjyFh0Wgo963zsVoXwlzDudY8c8qfLvM0130_assertion evidence source_evidence_literature NP360844.RAbXBrSv5De6UjyFh0Wgo963zsVoXwlzDudY8c8qfLvM0130_provenance.
- NP360844.RAbXBrSv5De6UjyFh0Wgo963zsVoXwlzDudY8c8qfLvM0130_assertion SIO_000772 12115363 NP360844.RAbXBrSv5De6UjyFh0Wgo963zsVoXwlzDudY8c8qfLvM0130_provenance.
- NP360844.RAbXBrSv5De6UjyFh0Wgo963zsVoXwlzDudY8c8qfLvM0130_assertion wasDerivedFrom befree-2016 NP360844.RAbXBrSv5De6UjyFh0Wgo963zsVoXwlzDudY8c8qfLvM0130_provenance.
- NP360844.RAbXBrSv5De6UjyFh0Wgo963zsVoXwlzDudY8c8qfLvM0130_assertion wasGeneratedBy ECO_0000203 NP360844.RAbXBrSv5De6UjyFh0Wgo963zsVoXwlzDudY8c8qfLvM0130_provenance.